A drug that mimics calcium and lowers parathyroid levels may help prevent bone fractures in patients with kidney failure who are on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Patients with kidney failure who are undergoing dialysis have an increased risk of bone fractures, and the risk of dying after a hip fracture in such a patient is double that of the general population. Unfortunately, none of the approved drugs for fracture prevention in osteoporosis in the general population are approved for use in patients on dialysis, and some are actually contraindicated.
IIT-B develops Membrane that will decrease Dialysis cost by 50%
Scientists at IIT-B have come up with a membrane to be used in dialysis that will not only cut the cost of dialysis by half, but also decrease the process time by 50 per cent.
Advertisement
Sharon Moe, MD (Indiana University School of Medicine and Roudebush Veterans Administration Medical Center) and her colleagues conducted a study to see whether cinacalet, a drug that lowers parathyroid hormone (PTH), can reduce the risk of fractures in patients receiving dialysis. These patients have elevated PTH levels due to problems with the way the body handles calcium when the kidneys are dysfunctional. In animals, lowering the level of PTH improves bone structure and reduces fractures.
The investigators conducted a planned secondary analysis of the EVOLVE trial, the largest study in hemodialysis patients to date. This study compared cinacalcet vs. placebo, on a background of standard of care. Clinical fractures were observed in 255 of 1935 (13.2%) patients randomized to placebo and 238 of 1948 (12.2%) patients randomized to cinacalcet. While cinacalcet did not reduce the rate of clinical fractures in unadjusted analyses, it had a protective effect against fractures after the researchers accounted for differences in patient characteristics and events that prompted patients to discontinue treatment.
"Our results showed a reduction in fracture risk by 16% to 29% in the patients receiving cinacalcet when adjusted for other fracture risk factors like age," said Dr. Moe.
Source: Newswise
"Our results showed a reduction in fracture risk by 16% to 29% in the patients receiving cinacalcet when adjusted for other fracture risk factors like age," said Dr. Moe.
Source: Newswise
Studies Say Many Dialysis Patients Unprepared for Emergencies and Disasters
Two studies say that patients on dialysis are very vulnerable during emergencies or disasters, but many are unprepared for such situations.
Advertisement
 Kidney Disease And Dialysis Treatment Is ExpensiveKidney disease can be very expensive and difficult to maintain hence insurers do provide some relief as do many organizations in states and counties. | Advertisement
|
Dialysis for Kidney Injury After Cardiac Surgery
Infusion with the antihypertensive agent fenoldopam does not reduce the need for dialysis or risk of death at 30 days, among patients with acute kidney injury after cardiac surgery.
Advertisement
Recommended Reading
Latest Drug News
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.